StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$237.85−0.34 (-0.14%)

Close on Nov 17, 2026Market cap $33.46BP/E 21.7Yield 1.01%

ResMed r&d expenses

Research and development expenses are spending on new products and technology.

ResMed's R&D Expenses for the twelve months ending Sep 30, 2026 was $393.82M, up 15.4% year over year. For fiscal 2026 it was $378.29M, up 14.2% from the year before. Over ten years it grew 12.3% a year on average. The highest annual figure on record is $378.29M in fiscal 2026.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jun 30, 2026$378.29M+14.2%
FY2025Jun 30, 2025$331.28M+7.7%
FY2024Jun 30, 2024$307.53M+6.9%
FY2023Jun 30, 2023$287.64M+13.4%
FY2022Jun 30, 2022$253.58M+12.6%
FY2021Jun 30, 2021$225.28M+11.6%
FY2020Jun 30, 2020$201.95M+11.8%
FY2019Jun 30, 2019$180.65M+16.4%
FY2018Jun 30, 2018$155.15M+7.4%
FY2017Jun 30, 2017$144.47M+21.8%
FY2016Jun 30, 2016$118.65M+3.3%
FY2015Jun 30, 2015$114.87M-2.8%
FY2014Jun 30, 2014$118.23M-1.6%
FY2013Jun 30, 2013$120.12M+9.5%
FY2012Jun 30, 2012$109.73M+19.3%
FY2011Jun 30, 2011$92.01M+22.3%
FY2010Jun 30, 2010$75.20M+19.3%
FY2009Jun 30, 2009$63.06M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$102.86M+15.0%
Q4 FY2026CQ2 2026Jun 30, 2026$105.73M+22.3%
Q3 FY2026CQ1 2026Mar 31, 2026$94.27M+12.3%
Q2 FY2026CQ4 2025Dec 31, 2025$90.97M+11.8%
Q1 FY2026CQ3 2025Sep 30, 2025$89.48M+12.5%
Q4 FY2025CQ2 2025Jun 30, 2025$86.44M+6.9%
Q3 FY2025CQ1 2025Mar 31, 2025$83.94M+8.9%
Q2 FY2025CQ4 2024Dec 31, 2024$81.37M+10.1%
Q1 FY2025CQ3 2024Sep 30, 2024$79.52M+5.0%
Q4 FY2024CQ2 2024Jun 30, 2024$80.86M+3.5%
Q3 FY2024CQ1 2024Mar 31, 2024$77.07M+0.8%
Q2 FY2024CQ4 2023Dec 31, 2023$73.88M+5.7%
Q1 FY2024CQ3 2023Sep 30, 2023$75.71M+19.8%
Q4 FY2023CQ2 2023Jun 30, 2023$78.14M+21.5%
Q3 FY2023CQ1 2023Mar 31, 2023$76.44M+14.4%
Q2 FY2023CQ4 2022Dec 31, 2022$69.87M+11.8%
Q1 FY2023CQ3 2022Sep 30, 2022$63.19M+5.4%
Q4 FY2022CQ2 2022Jun 30, 2022$64.32M+7.4%
Q3 FY2022CQ1 2022Mar 31, 2022$66.80M+19.4%
Q2 FY2022CQ4 2021Dec 31, 2021$62.51M+13.8%
Q1 FY2022CQ3 2021Sep 30, 2021$59.95M+9.9%
Q4 FY2021CQ2 2021Jun 30, 2021$59.88M+14.0%
Q3 FY2021CQ1 2021Mar 31, 2021$55.94M+8.7%
Q2 FY2021CQ4 2020Dec 31, 2020$54.94M+10.0%
Q1 FY2021CQ3 2020Sep 30, 2020$54.53M+13.5%
Q4 FY2020CQ2 2020Jun 30, 2020$52.52M+2.7%
Q3 FY2020CQ1 2020Mar 31, 2020$51.45M+8.1%
Q2 FY2020CQ4 2019Dec 31, 2019$49.94M+15.8%
Q1 FY2020CQ3 2019Sep 30, 2019$48.03M+23.8%
Q4 FY2019CQ2 2019Jun 30, 2019$51.14M+29.0%
Q3 FY2019CQ1 2019Mar 31, 2019$47.61M+27.2%
Q2 FY2019CQ4 2018Dec 31, 2018$43.11M+6.1%
Q1 FY2019CQ3 2018Sep 30, 2018$38.79M+3.7%
Q4 FY2018CQ2 2018Jun 30, 2018$39.66M+8.0%
Q3 FY2018CQ1 2018Mar 31, 2018$37.43M+6.6%
Q2 FY2018CQ4 2017Dec 31, 2017$40.64M+6.4%
Q1 FY2018CQ3 2017Sep 30, 2017$37.42M–
Q4 FY2017CQ2 2017Jun 30, 2017$36.71M–
Q3 FY2017CQ1 2017Mar 31, 2017$35.13M–
Q2 FY2017CQ4 2016Dec 31, 2016$38.19M–

More ResMed figures

See a number that looks wrong?